1006592-45-5

Basic information

• Product Name: (3aS,4S,6aR)-Hexahydro-2-oxo-N-(15-oxo-3,6,9,12-tetraoxa-16-azanonadec-18-yn-1-yl)-1H-thieno[3,4-d]imidazole-4-pentanamide
• Synonyms: (3aS,4S,6aR)-Hexahydro-2-oxo-N-(15-oxo-3,6,9,12-tetraoxa-16-azanonadec-18-yn-1-yl)-1H-thieno[3,4-d]imidazole-4-pentanamide;Biotin-PEG4-Amide propargyl;Biotin Alkyne *CAS 1006592-45-5*
• CAS NO: 1006592-45-5
• Molecular Formula: C24H40N4O7S
• Molecular Weight: 528.662
• Mol File: 1006592-45-5.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 822.9±65.0 °C(Predicted)
• Appearance: /
• Density: 1.174
• PKA: 13.90±0.40(Predicted)
• CAS DataBase Reference: (3aS,4S,6aR)-Hexahydro-2-oxo-N-(15-oxo-3,6,9,12-tetraoxa-16-azanonadec-18-yn-1-yl)-1H-thieno[3,4-d]imidazole-4-pentanamide(CAS DataBase Reference)
• NIST Chemistry Reference: (3aS,4S,6aR)-Hexahydro-2-oxo-N-(15-oxo-3,6,9,12-tetraoxa-16-azanonadec-18-yn-1-yl)-1H-thieno[3,4-d]imidazole-4-pentanamide(1006592-45-5)
• EPA Substance Registry System: (3aS,4S,6aR)-Hexahydro-2-oxo-N-(15-oxo-3,6,9,12-tetraoxa-16-azanonadec-18-yn-1-yl)-1H-thieno[3,4-d]imidazole-4-pentanamide(1006592-45-5)

Safety Data

• Hazardous Substances Data: 1006592-45-5(Hazardous Substances Data)

Usage

Description

(3aS,4S,6aR)-Hexahydro-2-oxo-N-(15-oxo-3,6,9,12-tetraoxa-16-azanonadec-18-yn-1-yl)-1H-thieno[3,4-d]imidazole-4-pentanamide is a complex organic compound with a unique molecular structure. It is characterized by its hexahydro-thienoimidazole core, which is fused with a pentanamide group and a 15-oxo-3,6,9,12-tetraoxa-16-azanonadec-18-yn-1-yl side chain. (3aS,4S,6aR)-Hexahydro-2-oxo-N-(15-oxo-3,6,9,12-tetraoxa-16-azanonadec-18-yn-1-yl)-1H-thieno[3,4-d]imidazole-4-pentanamide exhibits specific stereochemistry with the 3aS, 4S, and 6aR configurations, which may influence its biological activity and interactions with target molecules.

Uses

Used in Pharmaceutical Industry:
(3aS,4S,6aR)-Hexahydro-2-oxo-N-(15-oxo-3,6,9,12-tetraoxa-16-azanonadec-18-yn-1-yl)-1H-thieno[3,4-d]imidazole-4-pentanamide is used as a pharmaceutical agent for its potential therapeutic effects. (3aS,4S,6aR)-Hexahydro-2-oxo-N-(15-oxo-3,6,9,12-tetraoxa-16-azanonadec-18-yn-1-yl)-1H-thieno[3,4-d]imidazole-4-pentanamide's unique structure and stereochemistry may allow it to interact with specific biological targets, such as enzymes or receptors, to modulate their activity and produce desired pharmacological effects.
Used in Drug Delivery Systems:
In the field of drug delivery, (3aS,4S,6aR)-Hexahydro-2-oxo-N-(15-oxo-3,6,9,12-tetraoxa-16-azanonadec-18-yn-1-yl)-1H-thieno[3,4-d]imidazole-4-pentanamide can be employed as a component of targeted drug delivery systems. Its chemical properties and structural features may enable the development of novel carriers or conjugates that can improve the bioavailability, targeting, and therapeutic efficacy of associated drugs.
Used in Chemical Synthesis:
(3aS,4S,6aR)-Hexahydro-2-oxo-N-(15-oxo-3,6,9,12-tetraoxa-16-azanonadec-18-yn-1-yl)-1H-thieno[3,4-d]imidazole-4-pentanamide may also find applications in chemical synthesis, particularly for the preparation of complex organic molecules or bioactive compounds. Its unique structural elements could serve as key intermediates or building blocks in the synthesis of novel pharmaceuticals, agrochemicals, or other specialty chemicals.